首页> 美国卫生研究院文献>other >Sulfa Drugs as Inhibitors of Carbonic Anhydrase: New Targets for the Old Drugs
【2h】

Sulfa Drugs as Inhibitors of Carbonic Anhydrase: New Targets for the Old Drugs

机译:磺胺类药物作为碳酸酐酶抑制剂:旧药物的新目标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sulfa drugs are well-known antibacterial agents containing N-substituted sulfonamide group on para position of aniline ring (NH2RSO2NHR). In this study 2,4-dichloro-1,3,5-triazine derivatives of sulfa drugs, sulfamerazine (>1b), sulfaquinoxaline (>2b), sulfadiazine (>3b), sulfadimidine (>4b), and sulfachloropyrazine (>5b) (>1a–>5a) were synthesized and characterized. Their carbonic anhydrase inhibition activity was evaluated against bovine cytosolic carbonic anhydrase isozyme II (bCA II). For the sake of comparison the CA inhibition activity of the parent sulfa drugs (>1b–>5b) was also evaluated. A significant increase in CA inhibition activity of sulfa drugs was observed upon substitution with 2,4-dichloro-1,3,5-triazine moiety. Molecular docking studies were carried out to highlight binding site interactions. ADME properties were calculated to evaluate drug likeness of the compounds.
机译:磺胺类药物是在苯胺环对位(NH2RSO2NHR ')上包含N-取代磺酰胺基的著名抗菌剂。在这项研究中,磺胺类药物的2,4-二氯-1,3,5-三嗪衍生物,柳氮磺胺嘧啶(> 1b ),磺胺喹喔啉(> 2b ),磺胺嘧啶(> 3b ),磺胺嘧啶(> 4b )和磺胺氯吡嗪(> 5b )(> 1a – > 5a )合成并表征。评估了它们的碳酸酐酶对牛胞质碳酸酐酶同工酶II(bCA II)的抑制活性。为了进行比较,还评估了磺胺母体药物(> 1b – > 5b )的CA抑制活性。用2,4-二氯-1,3,5-三嗪部分取代后,观察到磺胺类药物的CA抑制活性显着增加。进行分子对接研究以突出结合位点的相互作用。计算ADME性质以评估化合物的药物相似性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号